The real-world safety profile of sodium-glucose co-transporter-2 inhibitors among older adults (≥ 75 years): a retrospective, pharmacovigilance study

Abstract Background As indications for sodium-glucose co-transporter-2 inhibitors (SGLT2i) are expanding, a growing number of older adults have become candidates for treatment. We studied the safety profile of SGLT2i among older adults. Methods A retrospective, pharmacovigilance study of the FDA’s g...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Adam Goldman, Boris Fishman, Gilad Twig, Emanuel Raschi, Tali Cukierman-Yaffe, Yonatan moshkovits, Alon Pomerantz, Ilan Ben-Zvi, Rachel Dankner, Elad Maor
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	BMC 2023-01-01
Schriftenreihe:	Cardiovascular Diabetology
Schlagworte:	Sodium-glucose co-transporter-2 inhibitors Older adults Diabetes Heart failure Diabetic ketoacidosis Fournier gangrene
Online-Zugang:	https://doi.org/10.1186/s12933-023-01743-5
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!